Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial. [electronic resource]
Producer: 20170731Description: 602-609 p. digitalISSN:- 2374-2445
- Aged
- Antineoplastic Agents -- administration & dosage
- Chemotherapy, Adjuvant
- DNA Mutational Analysis -- methods
- DNA, Neoplasm -- genetics
- Drug Administration Schedule
- Female
- Gastrointestinal Stromal Tumors -- drug therapy
- Humans
- Imatinib Mesylate -- administration & dosage
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Mutation
- Proto-Oncogene Mas
- Proto-Oncogene Proteins c-kit -- genetics
- Receptor, Platelet-Derived Growth Factor alpha -- genetics
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.